← Peptide library
Fat loss & metabolism

HGH Fragment 176-191

Also known as: HGH Frag 176-191 · AOD-9604 (related analogue) · Lipolytic fragment

A short fragment corresponding to the C-terminal region of human growth hormone, studied mainly for its reported fat-mobilizing (lipolytic) activity without the broader growth effects of full GH.

HGH Fragment 176-191 at a glance

NameHGH Fragment 176-191
Also known asHGH Frag 176-191, AOD-9604 (related analogue), Lipolytic fragment
CategoryFat loss & metabolism
TypePeptide
Sequence16-amino-acid C-terminal fragment of human growth hormone (residues 176-191)
Typical dose~250-500 mcg per day
FrequencyOnce or split across the day, often on an empty stomach
RouteSubcutaneous injection (research)
Half-lifeShort - estimated at roughly 30 minutes; not firmly established in humans.

Overview

HGH Fragment 176-191 is a synthetic peptide representing the tail end of the growth-hormone molecule. Research interest centers on the observation that this region appears to carry much of GH's fat-metabolizing activity while largely lacking its effects on IGF-1 and blood glucose. Most supporting data come from animal and laboratory studies; robust human evidence is limited. It is an investigational compound, not an approved drug.

How it’s thought to work

  • Appears to stimulate lipolysis (breakdown of stored fat) in adipose tissue.
  • Thought to reduce lipogenesis, limiting new fat accumulation.
  • Reported to act largely independently of the IGF-1 pathway in research models.
  • Mimics the fat-regulating portion of full-length growth hormone.

Researched uses

  • Fat reduction and body-composition research in animal models
  • Investigating GH-independent lipolytic pathways
  • Comparative studies with the related analogue AOD-9604

Commonly cited protocol

Typical dose~250-500 mcg per day
FrequencyOnce or split across the day, often on an empty stomach
RouteSubcutaneous injection (research)
NotesFasted timing is frequently mentioned in research discussions of lipolytic peptides.

Reconstitution

Commonly supplied as a 5 mg lyophilized vial. Reconstituting 5 mg with 2 mL of bacteriostatic water gives 2.5 mg/mL, so a 250 mcg dose is about 10 units on a U-100 syringe.

HGH Fragment 176-191 dosage calculator

The calculator below is pre-filled with HGH Fragment 176-191’s commonly cited vial size and dose. Adjust the vial amount, bacteriostatic water, or dose to match your own vial — it will show the exact insulin-syringe units to draw, the concentration, and how many doses the vial holds.

mg
mL
How much water you add is your choice — it doesn’t change your dose, only how many units you draw. Common:
Draw to
10 units
= 0.1 mL on a 1 mL (100 units) syringe
10 units0100
Concentration
2.5 mg/mL
Per unit
25 mcg/u
Doses per vial
20 × 250mcg
Volume
0.1 mL
📋 In plain English

Add 2 mL of bacteriostatic water to your 5 mg vial. That gives you about 20 doses of 250 mcg. For each dose, draw 10 units into a 100-unit insulin syringe.

See the full HGH Fragment 176-191 dosing chart (units for every dose & water amount), or open the full peptide calculator →

Cautions

  • A research chemical not approved by the FDA for human use; prohibited in competitive sport.
  • Human efficacy data for fat loss remain limited and mixed.
  • Long-term safety has not been established.
  • Research-grade purity varies widely by source.

HGH Fragment 176-191 FAQ

What is HGH Fragment 176-191?

A short fragment corresponding to the C-terminal region of human growth hormone, studied mainly for its reported fat-mobilizing (lipolytic) activity without the broader growth effects of full GH.

How does HGH Fragment 176-191 work?

Appears to stimulate lipolysis (breakdown of stored fat) in adipose tissue. Thought to reduce lipogenesis, limiting new fat accumulation. Reported to act largely independently of the IGF-1 pathway in research models. Mimics the fat-regulating portion of full-length growth hormone.

What is HGH Fragment 176-191 used for?

Fat reduction and body-composition research in animal models; Investigating GH-independent lipolytic pathways; Comparative studies with the related analogue AOD-9604.

What is a typical HGH Fragment 176-191 dose?

~250-500 mcg per day, Once or split across the day, often on an empty stomach, Subcutaneous injection (research). This is a commonly cited figure for context only, not medical advice.

How do you reconstitute HGH Fragment 176-191?

Commonly supplied as a 5 mg lyophilized vial. Reconstituting 5 mg with 2 mL of bacteriostatic water gives 2.5 mg/mL, so a 250 mcg dose is about 10 units on a U-100 syringe.

What is the half-life of HGH Fragment 176-191?

Short - estimated at roughly 30 minutes; not firmly established in humans.

Related fat loss & metabolism peptides

⚠️ Educational reference only — not medical advice. These compounds are largely research chemicals not approved for human use in most countries. Nothing here is a recommendation to obtain or administer any substance. Consult a qualified clinician.